Loading clinical trials...
Loading clinical trials...
Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells to Facilitate the Engraftment of a Single CCR5Δ32 Homozygous or Heterozygous Cord Blood Unit in Patients With HIV and Hematological Malignancies
Conditions
Interventions
Fludarabine
Cyclophosphamide
+4 more
Locations
5
United States
University of California San Francisco
San Francisco, California, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Case Western Reserve University
Cleveland, Ohio, United States
Cleveland Cord Blood Center
Cleveland, Ohio, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
October 6, 2022
Primary Completion Date
November 11, 2022
Completion Date
November 30, 2022
Last Updated
January 1, 2025
NCT06735690
NCT06074666
NCT04972942
NCT06395103
NCT07295951
NCT07523555
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions